APA (7th ed.) Citation

ElMenshawy, N., Ibrahim Fouda, M., Mofreh, M., Hisham El-Etriby, H., O Elnenaei, M., & Eissa, M. (2024). Impact of CD34/CD309 expression in circulating endothelial progenitor cells on prognosis and response to bortezomib therapy in multiple myeloma. Journal of Immunoassay & Immunochemistry, 45(5), 481. https://doi.org/10.1080/15321819.2024.2388614

Chicago Style (17th ed.) Citation

ElMenshawy, Nadia, Manal Ibrahim Fouda, Mohamed Mofreh, Heba Hisham El-Etriby, Manal O Elnenaei, and Mohamed Eissa. "Impact of CD34/CD309 Expression in Circulating Endothelial Progenitor Cells on Prognosis and Response to Bortezomib Therapy in Multiple Myeloma." Journal of Immunoassay & Immunochemistry 45, no. 5 (2024): 481. https://doi.org/10.1080/15321819.2024.2388614.

MLA (9th ed.) Citation

ElMenshawy, Nadia, et al. "Impact of CD34/CD309 Expression in Circulating Endothelial Progenitor Cells on Prognosis and Response to Bortezomib Therapy in Multiple Myeloma." Journal of Immunoassay & Immunochemistry, vol. 45, no. 5, 2024, p. 481, https://doi.org/10.1080/15321819.2024.2388614.